Drug Shortage Report for TOBI

Last updated on 2024-10-04 History
Report ID 192953
Drug Identification Number 02239630
Brand name TOBI
Common or Proper name TOBRAMYCIN
Company Name BGP PHARMA ULC
Market Status MARKETED
Active Ingredient(s) TOBRAMYCIN
Strength(s) 300MG
Dosage form(s) SOLUTION
Route of administration INHALATION INHALATION
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 56 AMPULES
ATC code J01GB
ATC description AMINOGLYCOSIDE ANTIBACTERIALS
Reason for shortage Demand increase for the drug.
Anticipated start date 2023-06-01
Actual start date 2023-05-31
Estimated end date 2024-10-01
Actual end date 2024-05-31
Shortage status Resolved
Updated date 2024-10-04
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v57 2024-10-04 French Compare
v56 2024-10-04 English Compare
v55 2024-09-24 French Compare
v54 2024-09-24 English Compare
v53 2024-09-03 French Compare
v52 2024-09-03 English Compare
v51 2024-08-12 French Compare
v50 2024-08-12 English Compare
v49 2024-08-06 French Compare
v48 2024-08-06 English Compare
v47 2024-07-29 French Compare
v46 2024-07-29 English Compare
v45 2024-07-23 French Compare
v44 2024-07-23 English Compare
v43 2024-07-03 French Compare
v42 2024-07-03 English Compare
v41 2024-06-25 French Compare
v40 2024-06-25 English Compare
v39 2024-05-17 French Compare
v38 2024-05-17 English Compare

Showing 1 to 20 of 57